Cargando…

MuLBSTA score in COVID-19 pneumonia and prediction of 14-day mortality risk: A study in an Indian cohort

BACKGROUND: The infectious agent which has caused the COVID-19 pandemic is a coronavirus named SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). On one end of the spectrum, a patient suffering from COVID-19 may be asymptomatic or have mild symptoms, while on the other end of the spectrum...

Descripción completa

Detalles Bibliográficos
Autores principales: Preetam, Mukul, Anurag, Aditya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132828/
https://www.ncbi.nlm.nih.gov/pubmed/34017730
http://dx.doi.org/10.4103/jfmpc.jfmpc_1766_20
_version_ 1783694968390418432
author Preetam, Mukul
Anurag, Aditya
author_facet Preetam, Mukul
Anurag, Aditya
author_sort Preetam, Mukul
collection PubMed
description BACKGROUND: The infectious agent which has caused the COVID-19 pandemic is a coronavirus named SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). On one end of the spectrum, a patient suffering from COVID-19 may be asymptomatic or have mild symptoms, while on the other end of the spectrum, a patient may develop numerous life-threatening complications. The way a host responds to infection by SARS-CoV-2 depends on various host factors like hypertension, old age, etc., The MuLBSTA scoring system takes into account various clinical and laboratory parameters and tries to predict the mortality risk for a patient. Besides, the validation of MuLBSTA score for mortality because of COVID-19 has not been extensively studied in an Indian set-up. This study is aimed at finding the association between the MuLBSTA score and the 14-day mortality risk because of COVID-19 in Indian population. MATERIALS AND METHODS: This study included 122 patients who were receiving treatment for SARS-CoV-2 infection at a tertiary hospital in Ranchi, Jharkhand. The disease severity (as per the ICMR guidelines), the MuLBSTA score, and the disease outcome of all patients were noted and analyzed in this study. RESULTS: A strong association was seen between a MuLBSTA score of ≥12 and the 14-day mortality risk in COVID-19 patients. CONCLUSION: The MuLBSTA scoring system is an easy to calculate model, which predicts the 14-day mortality risk because of SARS-CoV-2 infection. This may help the primary care physicians in stratifying and referring the patients who have a higher chance of developing severe complications.
format Online
Article
Text
id pubmed-8132828
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-81328282021-05-19 MuLBSTA score in COVID-19 pneumonia and prediction of 14-day mortality risk: A study in an Indian cohort Preetam, Mukul Anurag, Aditya J Family Med Prim Care Original Article BACKGROUND: The infectious agent which has caused the COVID-19 pandemic is a coronavirus named SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). On one end of the spectrum, a patient suffering from COVID-19 may be asymptomatic or have mild symptoms, while on the other end of the spectrum, a patient may develop numerous life-threatening complications. The way a host responds to infection by SARS-CoV-2 depends on various host factors like hypertension, old age, etc., The MuLBSTA scoring system takes into account various clinical and laboratory parameters and tries to predict the mortality risk for a patient. Besides, the validation of MuLBSTA score for mortality because of COVID-19 has not been extensively studied in an Indian set-up. This study is aimed at finding the association between the MuLBSTA score and the 14-day mortality risk because of COVID-19 in Indian population. MATERIALS AND METHODS: This study included 122 patients who were receiving treatment for SARS-CoV-2 infection at a tertiary hospital in Ranchi, Jharkhand. The disease severity (as per the ICMR guidelines), the MuLBSTA score, and the disease outcome of all patients were noted and analyzed in this study. RESULTS: A strong association was seen between a MuLBSTA score of ≥12 and the 14-day mortality risk in COVID-19 patients. CONCLUSION: The MuLBSTA scoring system is an easy to calculate model, which predicts the 14-day mortality risk because of SARS-CoV-2 infection. This may help the primary care physicians in stratifying and referring the patients who have a higher chance of developing severe complications. Wolters Kluwer - Medknow 2021-01 2021-01-30 /pmc/articles/PMC8132828/ /pubmed/34017730 http://dx.doi.org/10.4103/jfmpc.jfmpc_1766_20 Text en Copyright: © 2021 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Preetam, Mukul
Anurag, Aditya
MuLBSTA score in COVID-19 pneumonia and prediction of 14-day mortality risk: A study in an Indian cohort
title MuLBSTA score in COVID-19 pneumonia and prediction of 14-day mortality risk: A study in an Indian cohort
title_full MuLBSTA score in COVID-19 pneumonia and prediction of 14-day mortality risk: A study in an Indian cohort
title_fullStr MuLBSTA score in COVID-19 pneumonia and prediction of 14-day mortality risk: A study in an Indian cohort
title_full_unstemmed MuLBSTA score in COVID-19 pneumonia and prediction of 14-day mortality risk: A study in an Indian cohort
title_short MuLBSTA score in COVID-19 pneumonia and prediction of 14-day mortality risk: A study in an Indian cohort
title_sort mulbsta score in covid-19 pneumonia and prediction of 14-day mortality risk: a study in an indian cohort
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132828/
https://www.ncbi.nlm.nih.gov/pubmed/34017730
http://dx.doi.org/10.4103/jfmpc.jfmpc_1766_20
work_keys_str_mv AT preetammukul mulbstascoreincovid19pneumoniaandpredictionof14daymortalityriskastudyinanindiancohort
AT anuragaditya mulbstascoreincovid19pneumoniaandpredictionof14daymortalityriskastudyinanindiancohort